Van Den Driessche M, Van Malderen N, Geypens B, Ghoos Y, Veereman-Wauters G
Department of Pediatrics, University Hospitals Leuven, Belgium.
J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):433-8. doi: 10.1097/00005176-200010000-00019.
The lactose-[13C]ureide breath test (LUBT) is a novel, noninvasive test to determine orocecal transit time. Lactose ureide resists the action of brush border enzymes and is metabolized by colonic bacteria. The purpose of the present study was to adapt this breath test for children of various age groups and to determine whether it can be applied in infants, newborns, and preterms to study the development of small intestinal motility.
In a group of 20 children (3-17 years) in vitro stool analysis and in vivo LUBT results were compared. From each subject a blank stool sample and a sample produced after induction with unlabeled lactose ureide were incubated with 10 mg lactose-[13C]ureide in small, closed bottles. Ten-milliliter CO2 samples were aspirated from the bottles using a needle and a syringe every 30 minutes for 24 hours. All children performed the breath test after induction of 500 mg unlabeled lactose ureide three times the prior day. A liquid test meal (chocolate milk) with 250 mg lactose-[13C]ureide was ingested. Breath samples were collected every 15 minutes for 10 hours. In a second group of 32 children (age range, 0-3 years) consisting of 6 children between 1 and 3 years of age, 6 infants between 6 and 12 months, 13 infants between 0 and 6 months, and 7 preterm infants, only the in vitro stool analysis was performed. Stools were collected for stool incubation, as described.
The mean orocecal transit time in the group of 20 children aged 3 to 17 years was 255 minutes (range, 165-390 minutes). Stool incubations demonstrated a clear 13CO2 peak in all infants aged more than 8 months, indicating that their colonic bacterial enzymic activity hydrolyses lactose ureide. However, in all infants aged less than 6 months and in preterm infants, the 13CO2 signal was absent, indicating that those subjects were unable to hydrolyze lactose ureide.
Infants aged less than 6 months do not host the appropriate bacterial enzymic activity for splitting lactose ureide. The authors conclude that the LUBT can be applied in infants aged more than 8 months, after weaning to solid foods, to determine orocecal transit time.
乳糖-[13C]脲呼气试验(LUBT)是一种用于测定口盲肠转运时间的新型非侵入性检测方法。乳糖脲可抵抗刷状缘酶的作用,并由结肠细菌代谢。本研究的目的是使这种呼气试验适用于不同年龄组的儿童,并确定其是否可应用于婴儿、新生儿和早产儿,以研究小肠运动的发育情况。
比较了20名3至17岁儿童的体外粪便分析和体内LUBT结果。从每个受试者采集一份空白粪便样本和一份用未标记乳糖脲诱导后产生的样本,与10毫克乳糖-[13C]脲在小的密闭瓶中孵育。使用针头和注射器每30分钟从瓶中抽取10毫升二氧化碳样本,持续24小时。所有儿童在前一天诱导摄入500毫克未标记乳糖脲三次后进行呼气试验。摄入含250毫克乳糖-[13C]脲的液体试验餐(巧克力牛奶)。每15分钟采集一次呼气样本,持续10小时。在第二组32名0至3岁儿童中,包括6名1至3岁儿童、6名6至12个月大的婴儿、13名0至6个月大的婴儿和7名早产儿,仅进行了体外粪便分析。按照上述方法收集粪便用于粪便孵育。
20名3至17岁儿童的平均口盲肠转运时间为255分钟(范围为165至390分钟)。粪便孵育显示,所有8个月以上婴儿的13CO₂峰值明显,表明其结肠细菌酶活性可水解乳糖脲。然而,所有6个月以下婴儿和早产儿均未出现13CO₂信号,表明这些受试者无法水解乳糖脲。
6个月以下婴儿不具备分解乳糖脲所需的适当细菌酶活性。作者得出结论,LUBT可应用于8个月以上、断奶后食用固体食物的婴儿,以测定口盲肠转运时间。